|Articles|March 20, 2023
Size exclusion chromatography to determine AAV titers
Author(s)Thermo Fisher Scientific
This customer note will demonstrate the suitability of SEC for a fast and reproducible evaluation of adeno-associated virus (AAV) product titers
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
In-Vivo Cell Therapy Model Aims to Reduce Manufacturing Challenges
2
Top 10 Questions from CPHI Frankfurt: Building Pharma Resilience a Common Theme
3
2025 PharmSci 360 to Showcase Essential AI Integration and Emerging Technologies
4
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
5
